{"name":"Orbus Therapeutics, Inc.","slug":"orbus-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-12-02","type":"trial","source":"GlobeNewswire","summary":"Orbus Therapeutics Announces Publication of Phase 3 STELLAR - GlobeNewswire","headline":"Orbus Therapeutics Announces Publication of Phase 3 STELLAR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQSUl1bnJvZVNqc05xR1hsZnM4UmNhTU9OU3ZuN2dRblpGMHg3RnBoY2preUJPSDVGSmNJbjFGZ0ZVek96RmxFejBtNV9HeUttYXd3dDF1N0tjVkpmYWpDV2NCVFVlNERkOUJYb1drMnJZYmdpRGJXZHlxbTVpMEJxSTM4SWFrdktjRndrQnpTZTMySmJKQTloay1mWDFScU1YRkV1REJ6TkFVV1pvbDIw?oc=5","date":"2024-11-25","type":"trial","source":"Clinical Trials Arena","summary":"Orbus’s combo misses primary endpoint in Phase III brain cancer trial - Clinical Trials Arena","headline":"Orbus’s combo misses primary endpoint in Phase III brain cancer trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxQeVhsa2xJM0s1LVRQQ2pJVEFhcmNfQ3NUQV9URkJwRlJpUDJEdTFLaFIwUS03ckd0bU9tcmFyRFZQdXFSMUhZVmV2RlE5aVR6SkVoZGt4dVFwTmZtSGxmcThqYmxwbm13VnduZXR5T0t2WkF1dnN1RXpsYTRoN0ZBbWpwNDFybTJ6ejZiMHd0SU80SXk3V0xUSm15cTRRbGlRMllGQkdSdVdmVkJmdFI5cGdJR3RvbVZEME5adTNWWklldk5RQ0FHOXkwTVNBZVRkMUZZeDBMYmZEQ211S2tGSC1SelZWMUx2NHFrLXV5d1pablJXa2hfcGg0eUtGVGlLT0FyaGtqSWRHLW10NzZ3RDZYaDFkb1Nwam50ZWFjaDJHRkVDOTRFY1B2M09tVTJ3VW5PQ1RJWjRQeGpGV1FZNjUxU2JyVEhmRjVZa1Jiek9kb2hnN3lmVWhGdw?oc=5","date":"2023-03-22","type":"pipeline","source":"GlobeNewswire","summary":"Brain Cancer Market Size to Propel With the Active - GlobeNewswire","headline":"Brain Cancer Market Size to Propel With the Active","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE50NE11N2lRSHhHN1VQb1dnLVlmZjBQTGU0dGxwU0tJSG9hVUxNYXJVZ0I1aHBCdVlVbHNKVVdpQzlrSVN5cmxLX3pRQlJDQnlGQXVkeWE4eEcyTVk?oc=5","date":"2022-12-20","type":"pipeline","source":"EurekAlert!","summary":"3D-patient tumor avatars: Maximizing their potential for next-generation precision oncology - EurekAlert!","headline":"3D-patient tumor avatars: Maximizing their potential for next-generation precision oncology - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOd3BzaVNYSks2VWV4clgyTWFDVW51d2xiSW5ucDBLUzBpMjZ4M1NUMHlwMUpmM1BDV25QMm1QZC0zZGVCUTUzemlPV0JXVDFzOFpJeFZCT1BIbi1yREMyWDRxZEpfT2YxYm5LTTdWbzI2cXNzZ3FZRlNfTndvcGhiY3NvWThDV2xOaTZnNGdBRHhwR0hzaEZjV19SVUxQQ09RNnNCbjVZRUhhaER6MU9ZUlN5OUM?oc=5","date":"2021-05-12","type":"pipeline","source":"Private Equity Stakeholder Project PESP","summary":"After Millions in Settlements, H.I.G. Capital Faces Multiple Health Care Fraud Suits - Private Equity Stakeholder Project PESP","headline":"After Millions in Settlements, H.I.G. Capital Faces Multiple Health Care Fraud Suits","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPek9PbFlDOGdJNWJxTU1fWVdFcXNWbkJ6TllhWVdTSzdZanlNdjdyQkZTcjN4Z2VhUlRESU9CZ1V5eTJKeUZvS0Eyb1ZTOWRVSTk3VkRzd2ppSTNOMVlIQ19GZGtjVHE1NzR2aDRLZURZb2taaXpLMzNnaE95YVBvNXNIUzB5ZFRzSnc0T05pWWxmOTh5Y2hrZmc3dVBKYmVlaFdNN3BLZW9IZGtMbHUzdVEyeU0?oc=5","date":"2017-04-17","type":"trial","source":"Clinical Leader","summary":"Breakthrough Therapy Designation Helps Genentech Navigate Difficult Trials - Clinical Leader","headline":"Breakthrough Therapy Designation Helps Genentech Navigate Difficult Trials","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}